En Es
Categories

BÜHLMANN LABS

BÜHLMANN LABS

BÜHLMANN designs, develops, manufactures and sells medical diagnostic products and kits (IVD or RUO) in the areas of inflammation, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. It offers the largest menu of molecular diagnostic products and the broadest calprotectin product range, and has ...
Products Summary
Close

About BÜHLMANN LABS

BÜHLMANN designs, develops, manufactures and sells medical diagnostic products and kits (IVD or RUO) in the areas of inflammation, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. It offers the largest menu of molecular diagnostic products and the broadest calprotectin product range, and has a selection of unique, high-quality assays for routine use.

Recently updated

Anti-C1q Assay
Anti-C1q Antibodies

BÜHLMANN assays for detecting anti-C1q antibodies in serum or plasma can help identify patients with active Lupus Nephritis. Typically an increase in the titer of anti-C1q autoantibodies can be observed between a few weeks and 6 months before a flare of lupus nephritis occurs.
More details

MRP8/14 Assay
MRP8/14 ELISA

The MRP8/14 (S100A8/A9) assays allow for the precise and sensitive measurement of MRP8/14, a laboratory biomarker that has been reported to be useful in several inflammatory disorders including Rheumatoid arthritis. Serum MRP8/14 also serves as a marker for monitoring ongoing immune reactions, and its elevated levels have been shown to play an important role in the management of patients suffering from cardio-vascular pathologies.
More details

Gamma-Hydroxybutyric Acid Assay
GHB Enzymatic Assay

The GHB enzymatic assay is a three-reagent test intended for the quantitative detection of the abuse/intoxication of Gamma-Hydroxybutyric Acid (GHB), also known as liquid ecstasy. The assay allows for direct, quick, and easy quantification of exogenous intake of GHB and can be applied on clinical chemistry platforms.
More details

Clinical Laboratory

Anti-C1q Assay
Anti-C1q Antibodies

BÜHLMANN assays for detecting anti-C1q antibodies in serum or plasma can help identify patients with active Lupus Nephritis. Typically an increase in the titer of anti-C1q autoantibodies can be observed between a few weeks and 6 months before a flare of lupus nephritis occurs.
More details

MRP8/14 Assay
MRP8/14 ELISA

The MRP8/14 (S100A8/A9) assays allow for the precise and sensitive measurement of MRP8/14, a laboratory biomarker that has been reported to be useful in several inflammatory disorders including Rheumatoid arthritis. Serum MRP8/14 also serves as a marker for monitoring ongoing immune reactions, and its elevated levels have been shown to play an important role in the management of patients suffering from cardio-vascular pathologies.
More details

Gamma-Hydroxybutyric Acid Assay
GHB Enzymatic Assay

The GHB enzymatic assay is a three-reagent test intended for the quantitative detection of the abuse/intoxication of Gamma-Hydroxybutyric Acid (GHB), also known as liquid ecstasy. The assay allows for direct, quick, and easy quantification of exogenous intake of GHB and can be applied on clinical chemistry platforms.
More details

Angiotensin Converting Enzyme Assay
ACE High Sensitive

The BÜHLMANN ACE high-sensitive assay is designed to quantify increased ACE activity in CSF samples from suspected and confirmed neurosarcoidotic patients. The assay shows a detection limit of 1 U/L and can be applied either on microtiter plates with a kinetic reader or on some clinical chemistry analyzers.
More details

Basophil Activation Test
Flow CAST

The Flow CAST is intended for the determination of basophil activation in patient whole blood samples by flow cytometry. BÜHLMANN’s unique marker combination – CCR3 and CD63 – combines the simple gating properties for basophil detection by CCR3 with the solid application of the proven activation marker CD63 in one. Thanks to its easy protocol and smart marker combination the first results can be obtained within one hour – perfect conditions for routine laboratories.
More details

Neuroimmunology Assay
Anti-GM1 Autoantibodies ELISA

The anti-GM1 Autoantibodies ELISA by BÜHLMANN is an assay designed for the quantitative determination of IgG and/or IgM of auto-antibody isotype directed against GM1 in human serum using individual IgG- and IgM-conjugates. The assay is based on the enzyme-immunometric assay technique with the wells of the provided microtiter plate coated with gangliosides: GM1.
More details

SGPG Antibody Assay
Anti-SGPG Autoantibodies ELISA

The anti-SGPG Autoantibodies ELISA by BÜHLMANN is a semi-quantitative assay for determining IgM antibodies against SGPG. The BÜHLMANN anti-SGPG Autoantibodies ELISA is the only CE-marked assay for IVD worldwide.
More details

Lateral Flow Test Cassette Reader
Quantum Blue Reader 3rd Generation

The Quantum Blue Reader 3rd Generation is a lateral flow test cassette reader that analyzes line intensities by state of the art image analysis and translates them into a quantitative result within minutes and is ideal to obtain test results fast and speed up the clinical decision. It offers intuitive navigation with touch screen, easy step-by-step tutorial screens and additional fast track mode that allows for reading test cassettes in a quick sequential way.
More details

Serum Calprotectin Assay
BÜHLMANN sCAL Turbo

The BÜHLMANN sCAL turbo serum calprotectin assay is a flexible and powerful tool to be applied on most clinical chemistry analyzers with dramatically reduced hands-on that allows serum calprotectin result reporting within a very short time. Its wide measuring range covers the clinically relevant concentrations and includes automated re-run for extreme high-level concentrations without high dose hook effect up to >90 µg/mL.
More details

Anti-Infliximab Antibody Test
Quantum Blue Anti-Infliximab

The Quantum Blue Anti-Infliximab lateral flow rapid test for anti-infliximab antibody determination allows for a highly specific detection of antibodies against infliximab within 15 minutes with an excellent specificity of 95%. As a drug-sensitive assay, its ease of use and short incubation time offers fast and reliable qualitative measurement of free anti-drug antibodies against the biologic drug.
More details

Adalimumab Assay
Quantum Blue Adalimumab

The Quantum Blue Adalimumab assay is designed for the quantitative measurement of adalimumab trough levels in patient serum within minutes for drug dose adjustments. The assay range is from 1.3 to 35 μg/mL adalimumab in serum covering the desired therapeutic window of 5-12 μg/mL.
More details

Cellular Allergen Stimulation Test
CAST ELISA

CAST ELISA, a cellular allergen stimulation test, can also be considered as an in vitro allergy provocation test that enables the detection of IgE-mediated allergies as well as pseudo-allergies. The latter kind of allergy is best known for Aspirin (ASA) and other non steroidal anti-inflammatory drugs (NSAIDs) and various other drugs or food additives.
More details

Pancreatic Elastase Quantification Assay
BÜHLMANN fPELA Turbo

BÜHLMANN fPELA turbo, a turbidimetric immunoassay, is a flexible solution to be applied on most clinical chemistry analyzers, and marks a milestone in the automation of pancreatic elastase quantification. It allows very rapid and flexible random access use, as well as being the ideal solution for high throughput applications in the routine laboratory. The fPELA turbo assay reduces hands-on time dramatically and allows reporting pancreatic elastase results from human stool samples within the shortest time.
More details

Infliximab Rapid Test
Quantum Blue Infliximab

The Quantum Blue Infliximab is the first rapid test to measure infliximab in serum samples and is designed for the selective measurement of infliximab by a sandwich immunoassay. The assay provides a quantitative result within 15 minutes of incubation time. This offers the possibility to health care providers to act immediately before infusion of the next infliximab dose, offering the possibility to health care providers to act immediately before infusion of the next infliximab dose.
More details

CIC-C1q ELISA Test
BÜHLMANN CIC-C1Q ELISA

The BUHLMANN CIC-C1Q ELISA is intended for the quantitative in vitro diagnostic determination of circulating immune complexes (CIC) in serum and plasma of patients with various autoimmune and other CIC-related diseases. The FDA 510k cleared assay offers clinicians and researchers a tool that provides useful clinical information regarding immunopathology, prognosis, and follow-up of rheumatic and autoimmune disorders.
More details

Fecal Calprotectin Assay
BÜHLMANN fCAL ELISA

The BÜHLMANN fCAL ELISA is an in vitro diagnostic assay intended for the quantitative measurement of fecal calprotectin in human stool. It aids in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC) and aids in the differentiation of IBD from irritable bowel syndrome (IBS) in conjunction with other laboratory and clinical findings. The FDA 510k cleared, non-invasive, sensitive and specific assay is accurate, precise, efficient and offers reliable information to aid clinicians in selecting patients for further diagnostic procedures.
More details

Stool Extraction Device
CALEX Cap

The CALEX Cap is the first and only stool extraction device suitable for safe air and land transportation, offering an efficient, convenient and hygienic extraction of stool samples. In addition to offering stability of the extracts for three days at room temperature, it is fully compatible with total laboratory automation (TLA) solutions, increasing the speed of sample processing and reducing hands-on time.
More details

CRP Assay
Quantum Blue CRP

The Quantum Blue C-Reactive Protein (CRP) lateral flow assay is a sandwich-type immunoassay designed for the quantitative determination of CRP in human serum in combination with the BÜHLMANN Quantum Blue reader within 22 minutes. It is an ideal tool to accompany the calprotectin determination for establishing an IBD patient inflammation profile during the course of the disease.
More details

Anti-MAG ELISA Test
anti-MAG ELISA

The anti-MAG ELISA test is based on highly-purified MAG from human brain to reliably quantify anti-MAG antibodies in immune-mediated demyelinating neuropathies. It is characterized by outstanding sensitivity and specificity and can be used as stand-alone test or in combination with BÜHLMANN GanglioCombi MAG ELISA to confirm auto-antibodies against MAG.
More details

Enzyme Kinetic Assay
ACE KINETIC

The Angiotensin Converting Enzyme (ACE) kinetic assay allows clinical routine laboratories to measure enzyme activity in serum using an easy to use procedure on most open clinical chemistry platforms. The CE-marked kit provides ready-to-use substrates and highly stable calibrator and controls, which remain stable for six months at 2-8°C.
More details

Fecal Calprotectin Assay
BÜHLMANN fCAL turbo

The BÜHLMANN fCAL turbo is an immuno turbidimetric fecal calprotectin assay that provides flexible and random access application on all major clinical chemistry platforms. The assay covers a measuring range from 20 to 8000 µg/g calprotectin and delivers results within 10 minutes.
More details

Point-Of-Care Testing

Lateral Flow Test Cassette Reader
Quantum Blue Reader 3rd Generation

The Quantum Blue Reader 3rd Generation is a lateral flow test cassette reader that analyzes line intensities by state of the art image analysis and translates them into a quantitative result within minutes and is ideal to obtain test results fast and speed up the clinical decision. It offers intuitive navigation with touch screen, easy step-by-step tutorial screens and additional fast track mode that allows for reading test cassettes in a quick sequential way.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions